Advertisement

Topics

Locus Discovery Incorporated Company Profile

12:00 EDT 25th June 2018 | BioPortfolio

Locus Discovery Inc. is a privately held chemogenomics biopharmaceutical company organized in September 1999, and is based on technology exclusively licensed from the Sarnoff Corporation (SRI International). The Locus Discovery process is a novel computational approach for rapidly designing small molecule therapeutic compounds that can act as antagonists or agonists of protein activity.

Location

201 Washington Road, 3-075
Princeton
NJ
08543
United States of America

Contact

Phone: (215) 358 2000
Fax: (215) 358 2010
Email: locus-info@locusdiscovery.com


PubMed Articles [759 Associated PubMed Articles listed on BioPortfolio]

Systematic Discovery of RNA Binding Proteins that Regulate MicroRNA Levels.

RNA binding proteins (RBPs) interact with primary, precursor, and mature microRNAs (miRs) to influence mature miR levels, which in turn affect critical aspects of human development and disease. To und...

Designing Epigenome Editors: Considerations of Biochemical and Locus Specificities.

The advent of locus-specific protein recruitment technologies has enabled a new class of studies in chromatin biology. Epigenome editors enable biochemical modifications of chromatin at almost any spe...

The retinal locus of fixation in simulations of progressing central scotomas.

Patients with central scotoma use a preferred retinal locus (PRL) of fixation to perform visual tasks. Some of the conditions that cause central scotoma are progressive, and as a consequence, the PRL ...

Translation of innovative chemistry into screening libraries: an exemplar partnership from the European Lead Factory.

The identification of high-quality starting points for drug discovery is an enduring challenge in medicinal chemistry. Yet, the chemical space explored in discovery programmes tends be limited by the ...

Protac-induced Protein Degradation in Drug Discovery: Breaking the Rules - or Just Making New Ones?

Targeted protein degradation, using bifunctional small molecules (Protacs) to remove specific proteins from within cells, has emerged as a novel drug discovery strategy with the potential to offer the...

Clinical Trials [224 Associated Clinical Trials listed on BioPortfolio]

Locus of Control and Spirituality in Palliative Care Patients

Primary Objectives: 1. To determine whether the degree of spirituality/religiosity as determined by the Duke University Religion Index and Functional Assessment of Chronic Illness ...

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

LOC387715/HTRA1 Variants in Polypoidal Choroidal Vasculopathy in a Korean Population

This study is to investigate whether variants in the LOC387715 locus and the HtrA serine peptidase 1 (HTRA1) gene within the 10q26 locus are associated with polypoidal choroidal vasculopat...

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Companies [1133 Associated Companies listed on BioPortfolio]

Locus Discovery Incorporated

Locus Discovery Inc. is a privately held chemogenomics biopharmaceutical company organized in September 1999, and is based on technology exclusively licensed from the Sarnoff Corporation (SRI Internat...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Locus Pharmaceuticals, Inc.

Locus Pharmaceuticals is a privately held pharmaceutical company focused on developing novel, small molecule therapeutic drugs to address major unmet medical needs. The foundation and competitiveness ...

Locus Genex Oy

Monoclonal Antibodies to Human Neurotransmitter Substances.manufacturer and supplier of monoclonals antibodies.

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including www.discoveryhealth.com, as well as its Continuing Medical Education (CME) business and ...

More Information about "Locus Discovery Incorporated" on BioPortfolio

We have published hundreds of Locus Discovery Incorporated news stories on BioPortfolio along with dozens of Locus Discovery Incorporated Clinical Trials and PubMed Articles about Locus Discovery Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Locus Discovery Incorporated Companies in our database. You can also find out about relevant Locus Discovery Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record